Coronavirus Notebook: US FDA Cuts Hotline Hours, Regulatory Relief May Be Permanent, Trump's Hydroxychloroquine Prescription

Dispatches from a world turned upside down include approval of more hydroxychloroquine ANDAs, a window into what post-pandemic regs at the US FDA might look like, and some bad news for night shift works who need coronavirus advice from the agency.

3D_Coronavirus
The FDA decided to reduce the hours its coronavirus emergency line will be available in order to meet current needs. • Source: Shutterstock

As the completely abnormal starts to feel routine, the Pink Sheet offers periodic dispatches about how the coronavirus pandemic is changing the operations of sponsors and regulators. Here are some recent stories from the United States.

In another potential sign of progress fighting the coronavirus pandemic, the FDA reduced the hours of its industry hotline for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics